Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Benzydamine hydrochloride 1.5 mg, cetylpyridinium chloride 5.5 mg, pholcodine 1.33 mg per 2.6 g Lozenge Barratt Pharmaceuticals Pty Limited, Blacktown, New South Wales, Australia Difflam Anti-Inflammatory Cough Thiamine hydrochloride 100 mg/ml Injection David Bull Laboratories Limited, Mulgrave North, Victoria, Australia Codeine phosphate 9.75 mg, doxylamine succinate 5 mg, paracetamol 450 mg Tablet Sigma Pharmaceuticals Pty Limited, Croydon, Victoria, Australia Mersyndol Codeine phosphate 8 mg, doxylamine succinate 5 mg, paracetamol 500 mg, Gemfibrozil 300 mg Tablet Wellcome Australia Limited, Cabarita, New South Wales, Australia Codral Tension Headache Gemfibrozil 300 mg Capsule Apotex Inc., Weston, Ontario, Canada Apo-Gemfibrozil Human Menopausal Gonadotrophin FSH 75IU/LH 35IU, FSH 150IU/LH 70IU. Note: This replaces the entry in the notice published in the New Zealand Gazette, 24 February 1994, No. 16, page 909, notice number 1435. Lyophilisate for IM injection Industria Farmaceutica Serono, Roma, Italy and Laboratoires Serona SA, Aubonne, Switzerland Pergogreen Dated this 28th day of March 1994. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.